HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 16:47
HUTCHMED Debt to Equity Ratio: 0.1109 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1109 |
| December 31, 2023 | 0.1086 |
| June 30, 2023 | 0.0513 |
| December 31, 2022 | 0.0297 |
| June 30, 2022 | 0.0005 |
| December 31, 2017 | 0.0649 |
| June 30, 2017 | 0.2474 |
| December 31, 2016 | 0.2539 |
| June 30, 2016 | 0.2347 |
| June 30, 2015 | 0.5135 |
| Date | Value |
|---|---|
| June 30, 2014 | 0.6202 |
| December 31, 2013 | 0.5796 |
| June 30, 2013 | 0.6145 |
| December 31, 2012 | 0.5358 |
| June 30, 2012 | 0.4477 |
| December 31, 2011 | 0.4637 |
| June 30, 2011 | |
| December 31, 2010 | 0.4114 |
| June 30, 2010 | 0.2587 |
| December 31, 2009 | 0.1253 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0005
Minimum
Jun 2022
0.1109
Maximum
Jun 2024
0.0602
Average
0.0513
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.7299 |
| AstraZeneca PLC | 0.8173 |
| Sino Biopharmaceutical Ltd | 0.2896 |
| Regencell Bioscience Holdings Ltd | -- |
| Prenetics Global Ltd | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.261B |
| Total Liabilities (Quarterly) | 508.85M |
| Shareholders Equity (Quarterly) | 740.08M |
| Current Ratio | 2.612 |
| Net Debt Paydown Yield | -0.73% |